MJC2 LIMITED

Financial Health Score: B+

Explanation: MJC2 LIMITED exhibits the financial equivalent of a robust immune system with zero debt and a strong cash position, indicating no immediate risk of financial distress. However, the patient is suffering from a localized ailment: a sharp drop in core operating profitability and a heavily congested balance sheet clogged with over £3.1 million in "Other Debtors." While the company is in no danger of flatlining, its underlying operational pulse is weaker than it appears, and the quality of its assets requires immediate diagnostic investigation.

Key Vital Signs

1. Blood Pressure (Liquidity & Solvency): 140/90 (Elevated but Stable) The company has zero current liabilities and zero long-term debt. A current ratio that approaches infinity (current assets vs. zero current liabilities) means the business has absolutely no short-term financial pressure. However, like high blood pressure, this "hyper-solvency" can be a symptom of inefficient capital allocation—capital is sitting idle rather than being put to work to generate higher returns.

2. Pulse (Cash Flow): 72 bpm (Healthy and Steady) Cash at bank increased from £400,171 to £434,344. The business is generating a positive, steady cash pulse, ensuring it can comfortably meet its day-to-day operational needs without relying on external life support (overdrafts or loans).

3. Temperature (Profitability): 37.5°C (Running Slightly Hot, but Dropping) Turnover showed a mild, healthy increase from £689,620 to £703,444. However, the operating profit temperature dropped significantly from £137,006 in 2024 to just £34,829 in 2025. The 2024 figures were artificially inflated by a large one-off £435,005 injection of "Other operating income" which masked hefty distribution costs. With that income gone in 2025, the underlying operational margin reveals a rather thin 5% operating profit margin, which is lean for a software development firm.

4. Cholesterol (Asset Quality): High (Potential Blockage) Total assets stand at a mighty £4.16 million, but £3.17 million of that is tied up in "Other Debtors." Just as high cholesterol restricts healthy blood flow, having 76% of your total assets locked up in non-trade debtor balances restricts financial fluidity and represents a significant concentration risk.

Diagnosis

The patient is suffering from Asset Congestion and Margin Compression.

At first glance, MJC2 LIMITED looks like a picture of health: a 35-year-old company with £4.16 million in net assets and not a single penny of external debt. But looking under the hood reveals an imbalance. The balance sheet is heavily weighted towards "Other Debtors" (£3,170,554). For a software design and development firm with only £170k in trade debtors, this figure is highly anomalous. It suggests the company may be acting as a bank, lending out large sums to related parties, directors, or third parties. If these funds are not recoverable, the company's net worth will take a massive, sudden hit.

Operationally, the 2025 accounts strip away the anomalous "other income" seen in 2024 and reveal the true core profitability. Earning just £34,829 on £703,444 of revenue suggests that the company's cost base (particularly distribution costs of £546,613) is consuming the vast majority of its revenue. For a software company—which typically enjoys high gross margins—this suggests either aggressive reinvestment, sub-contracting costs, or an unsustainable cost structure.

Recommendations

1. Conduct a Biopsy on "Other Debtors": The most critical step is to investigate the £3.17m "Other Debtors." Management must confirm the nature of these balances, who the debtors are, and their ability to repay. If these are director loans, they should be formally documented and reviewed for compliance with Corporation Tax rules (e.g., Section 455 tax on overdrawn director's loan accounts). If they are deemed unrecoverable, they must be written off immediately to present a true picture of health.
2. Cardio Workout (Improve Operational Margins): A 5% operating margin is too low for a sustainable software enterprise. The company needs to review its distribution and administrative costs. Are distribution costs primarily subcontractor labour? If so, billing rates and project margins need to be reviewed to ensure the company is not simply passing revenue through its veins without retaining any nutrients (profit).
3. Vitamin Distribution (Capital Allocation): With £434k in cash and no debt, the company has significant financial slack. The shareholders should evaluate whether this cash is best held on the balance sheet earning minimal interest, reinvested into higher-yielding software development, or distributed as dividends to clear the accumulated P&L reserve in a tax-efficient manner.